At KSh≈10, Liberty trades at only ~0.5x book despite rising interest income and strong equity buffers. If the underwriting cycle stabilizes (claims retreat from 2025 peaks) and investment markets improve, profitability could rebound. The board’s commitment to a KSh0.50 base dividend (supported by strong capital) yields a ~5% dividend yield now, implying upside if the market rewards that yield with a higher multiple. The Tanzanian exit clarifies focus and removes low-margin operations, streamlining growth. Macro tailwinds (economic growth, higher future bond yields) could boost long-term investment returns. In sum, undervalued book + a safe cash yield + solid solvency points to a rerating.

The short-term insurance cycle is currently weak. If motor/medical/property claims remain elevated (e.g. due to inflation or adverse weather/events), the combined ratio could stay >100%, keeping profits low. Investment returns are also cyclical: any financial market dip (or further interest rate cuts) would hurt income. Regulatory changes (e.g. higher capital requirements) or new taxes on insurers could pressure returns. Competitors (large groups, new entrants) may limit market share/growth. IFRS 17 also adds volatility to earnings and book value (through technical reserves changes) which could unsettle valuations. Finally, the stock is thinly traded (low liquidity), so market pricing may overreact to news.

Liberty Kenya Holdings Research

May 18
6 min read

Target price: KSh 13.53

Current Fair value: KSh 10.24

Summary

Liberty Kenya (NSE: LBTY) is a Nairobi‐listed insurance holding company (Liberty Holdings (SA) subsidiary) whose core subsidiaries are Liberty Life Kenya (life insurance), Heritage Insurance Kenya (general insurance) and CFC Investments (asset management). The stock trades very cheaply: as of May 2026 it was ~KSh9.80 per share (P/B ≈0.5x, given ~KSh10.08 bn equity). Recent results show continued revenue growth (+8.5% in 2025) but sharply higher claims that roughly halved underwriting profit. The balance sheet remains very strong (Heritage and Life subsidiaries both carry capital adequacy >> regulatory minimum) and the board maintains a high recurring payout (KSh0.50/share in 2024 & 2025). One-off events have been significant: in 2025 Liberty sold its 60% Heritage Tanzania stake (net gain ~KSh503m) and paid a special dividend (0.50–0.60/sh). Our analysis concludes that Liberty Kenya’s intrinsic value likely exceeds the current price. Using a dividend‐discount model (base DPS=KSh0.50, conservative growth and ~12% cost of equity) and a price‐to‐book approach yields a fair value in the mid‑KShteens. We set a target of ~KSh14–15 (upside ~40–50%) and rate Liberty Kenya BUY (moderate confidence), noting it is arguably undervalued as an “asset‐backed” insurer.

Key evidence

Business model: Liberty Kenya offers both life and general insurance products, plus asset management and property development. It is the holding co for Liberty Life Kenya Assurance (long‐term business), Heritage Insurance Company Kenya (general insurance) and CFC Investments (asset management). It has operations in Kenya and (until 2025) Tanzania; after exiting Heritage Tanzania, focus is on Kenyan market. It is majority‐owned by South Africa’s Liberty Holdings.
Financial performance: Total insurance revenue rose 8.5% in FY2025 to KSh11.88 bn (KSh10.95bn in 2024). However, rising claims heavily compressed margins: the insurance service result (premiums minus claims) plunged to KSh478m in 2025 from KSh1.06bn a year earlier. This drove Profit Before Tax down 47.8% (KSh1.091bn vs KSh2.091bn) and Net Earnings (including discontinued ops) down 65% to KSh487m. On the plus side, underwriting expenses were disciplined – e.g. Heritage Kenya’s expense ratio improved (24% vs 29%). Investment income also softened (KSh4.02bn vs KSh4.89bn), reflecting weaker fair‐value gains and falling interest rates. Book value per share is ~KSh18.8 (total equity ~KSh10.08bn over ~535.7m shares), while the share price of ~KSh10 implies P/B ≈0.53.
Capital & solvency: The group’s capital ratios are robust and above internal/Regulator targets. For example, Heritage Kenya’s solvency ratio was ~466% (vs 451% prior year) and Liberty Life’s ~244%. Both subsidiaries retain AA+(KE) ratings (GCR). IFRS 17 adoption (fully implemented 2023) has reshuffled reserves and intangibles, but management states all insurance entities are “well above regulatory targeted levels”. This strong capital underpins the steady dividends and provides a large cushion for shocks.
Dividends & cash returns: The Board has resumed paying dividends after a hiatus: KSh0.373/share was paid for 2023 (1st final dividend in years). In FY2024 the total distribution was KSh1.00 (of which KSh0.50 was a special payout from the Tanzanian sale). For FY2025 the board recommended KSh0.50 (final), unchanged from the base 2024 level, and no special payout. In short, the recurring dividend is now KSh0.50. Notably, all net proceeds from the sale of Heritage Tanzania (KSh503m net of tax) were returned to shareholders via a KSh0.50–0.60/sh special in mid-2025. Going forward, management signals that any excess capital will be similarly returned.
Industry norms – Insurer valuation: As with peers, Liberty is best valued by book and dividends rather than naive FCF. Insurers often trade by P/B and have complex cash flows. For example, Investopedia notes that DCF is “less valuable because cash flow is more difficult to gauge” in insurers, and P/B is a primary metric. (By analogy, Life insurer MetLife trades at ~0.5x book, which was cited as an attractive entry.) Liberty’s P/B ~0.53x is very low by such standards.

Valuation

We use three lenses:

Dividend Discount (DDM): Base DPS is KSh0.50 (we exclude one-off specials). If we assume no growth (g≈0%) and cost of equity Ke≈10–12% (reflecting Kenya risk), the perpetuity value is KSh4.17–5.0. If we assume modest growth (e.g. g=3–5%, reflecting inflation-level growth in profits) and Ke12–13%, the model yields ~KSh8–12. For example, DPS=0.50, g=5%, Ke=12% gives value ≈0.50*(1.05)/(0.12−0.05) ≈KSh7.5. The output is highly sensitive to assumptions (Ke and g). Even so, a DDM suggests fair value above the current ~KSh10 only if growth or yield arguments are optimistic. However, if we include a normalized mid-cycle DPS (say KSh0.60) or lower Ke (10%), DDM values move into the teens.
Price/Book: December 2025 equity ≈KSh10.08 bn, or KSh18.8/sh. At KSh9.6–10.0 market price, P/B ≈0.5–0.53. By actuarial/book rules, insurers are often “fair” near P/B=1 (MetLife cited at 0.5x). If we apply even a modest re‐rating (say 0.75x book), the target would be ~KSh14.1 (0.75×18.8). If we stripped out IFRS17 intangible (~KSh1.48bn) for a tangible book basis, P/B is ~0.61; raising this to 0.8 implies ~KSh15.0. Thus a conservative P/B-based fair value is in the KSh13–15 range.
Sum‐of‐Parts / Asset approach: Roughly, Liberty’s net assets are split among Heritage Kenya, Liberty Life Kenya, and CFC Investments (plus cash). Heritage Kenya (short-term) earned KSh1.02bn PBT in 2025 and boasts a 466% solvency; Liberty Life (long-term) earned less (reported combined net ~KSh0.05bn after tax), with equity ~KSh2.74bn. Both have strong ratings (AA+(KE)). If we apply conservative P/B of ~0.7 to Heritage and 0.6 to Liberty Life, add CFC and cash, we again get value above the current price. (Detailed SOTP here is limited by data; the high combined capital suggests significant “hidden” value beyond current earnings.)

Stress‐Test: The biggest lever is DPS growth vs discount rate. If yields rise or float costs shrink (better combined ratio), DPS could exceed 0.50 and lift value. Conversely, if claims worsen or discount (Ke) rises (higher risk premium), DDM value could fall below KSh6. P/B valuation is more stable: even assuming book falls 10% vs price flat still yields ≈0.6x PB (≈KSh11). The fact that Liberty’s solvency and equity are much larger than price implies a margin of safety.

Bull / Bear Case

Bull case: At KSh≈10, Liberty trades at only ~0.5x book despite rising interest income and strong equity buffers. If the underwriting cycle stabilizes (claims retreat from 2025 peaks) and investment markets improve, profitability could rebound. The board’s commitment to a KSh0.50 base dividend (supported by strong capital) yields a ~5% dividend yield now, implying upside if the market rewards that yield with a higher multiple. The Tanzanian exit clarifies focus and removes low-margin operations, streamlining growth. Macro tailwinds (economic growth, higher future bond yields) could boost long-term investment returns. In sum, undervalued book + a safe cash yield + solid solvency points to a rerating.
Bear case: The short-term insurance cycle is currently weak. If motor/medical/property claims remain elevated (e.g. due to inflation or adverse weather/events), the combined ratio could stay >100%, keeping profits low. Investment returns are also cyclical: any financial market dip (or further interest rate cuts) would hurt income. Regulatory changes (e.g. higher capital requirements) or new taxes on insurers could pressure returns. Competitors (large groups, new entrants) may limit market share/growth. IFRS 17 also adds volatility to earnings and book value (through technical reserves changes) which could unsettle valuations. Finally, the stock is thinly traded (low liquidity), so market pricing may overreact to news.

Catalysts and Risks

Catalysts: Expanded digital distribution of life and micro-insurance products could drive new premium growth. The CEO has flagged new product launches (e.g. retail medical) to improve margins. Any broad market recovery or higher interest environment would raise investment income and released reserves, benefiting EPS. If management uses excess capital for share buybacks or consistent extra dividends, that could narrow the valuation gap to book. Positive analyst coverage or inclusion in regional indices could also lift sentiment.
Risks: Persistently rising claim costs (medical inflation, accident rates) are the largest threat to earnings. A drop in interest rates (global monetary easing) would hurt reinvestment yields. Foreign exchange weakness (Kenya shilling depreciation) increases the local cost of imported parts/medical goods, indirectly boosting claims. Regulatory tightening (e.g. new IFRS standards, solvency bands) could require more capital. If Liberty Holdings (SA) changes strategy or funding (it holds ~63% of LBTY) that could affect strategy. And if another currency crisis or macro-shock hits Kenya, insurance demand could fall.

Recommendation

Buy (Current price ~KSh9.80). Our target is KSh13–15, implying 30–50% upside. This target is supported by multiple approaches: DDM (with modest growth) and P/B re-rating both point to mid-teens value. Key reasons: (1) The stock is trading far below book (P/B0.5) despite strong capital buffers. (2) Management’s dividend policy provides a ~5% yield (KSh0.50 base) with room for special dividends when excess capital emerges. (3) The company’s solvency and ratings (AA+) suggest low likelihood of distress. The main risks (claims and investment volatility) are balanced by the large equity cushion. Our confidence is moderate – if underwriters continue to struggle or if financial markets worsen, performance may disappoint; but given the valuation margin to tangible assets, we view the downside as limited and the long-term risk/reward as favourable.